Possible involvement of RasGRP4 in leukemogenesis

International Journal of Hematology

Volumn 89, Issue 4, 2009, Pages 470-481

  Watanabe Okochi, Naoko ^a   Oki, Toshihiko ^a   Komeno, Yukiko ^a   Kato, Naoko ^a   Yuji, Koichiro ^a   Ono, Ryoichi ^b   Harada, Yuka ^c   Harada, Hironori ^c   Hayashi, Yasuhide ^d   Nakajima, Hideaki ^a   Nosaka, Tetsuya ^b   Kitaura, Jiro ^a   Kitamura, Toshio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MIE UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d Gumna Children S Medical Center   (Japan)

Author keywords

AML1; CDNA library; Class I mutation; Leukemogenesis; RasGRP4

Indexed keywords

COMPLEMENTARY DNA; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAS GUANYL RELEASING PROTEIN 4; UNCLASSIFIED DRUG; RASGRP4 PROTEIN, HUMAN; RASGRP4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL LINE; CELL LINE HF6; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA LIBRARY; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LEUKEMOGENESIS; MOLECULAR CLONING; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NONHUMAN; NUCLEOTIDE SEQUENCE; T CELL LEUKEMIA; ANIMAL; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; LEUKEMIA; METABOLISM; MUTATION; PATHOLOGY;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA; MICE; MUTATION; NEOPLASM TRANSPLANTATION; POLYMORPHISM, GENETIC; RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS;

EID: 67449116506     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0299-0     Document Type: Article

References (39)

1. A Beghini P Peterlongo CB Ripamonti L Larizza R Cairoli E Morra 2000 C-kit mutations in core binding factor leukemias Blood 95 726 727
2. YY Wang GB Zhou T Yin B Chen JY Shi WX Liang 2005 AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec Proc Natl Acad Sci USA 102 1104 1109 10.1073/pnas.0408831102 (Pubitemid 40170733)
3. A Shimada T Taki K Tabuchi A Tawa K Horibe M Tsuchida 2006 KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group Blood 107 1806 1809 10.1182/blood-2005-08-3408 (Pubitemid 43289357)
4. N Yamashita M Osato L Huang M Yanagida SC Kogan M Iwasaki 2005 Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukemogenesis in BXH2 mice Br J Haematol 131 495 507 10.1111/j.1365-2141.2005.05793.x (Pubitemid 43899649)
5. RS Care PJ Valk AC Goodeve FM Abu-Duhier WM Geertsma-Kleinekoort GA Wilson 2003 Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias Br J Haematol 121 775 777 10.1046/j.1365-2141.2003.04362.x (Pubitemid 36718195)
6. N Boissel H Leroy B Brethon N Philippe S de Botton A Auvrignon 2006 Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) Leukemia 20 965 970 10.1038/sj.leu.2404188 (Pubitemid 43797286)
7. A Beghini CB Ripamonti R Cairoli G Cazzaniga P Colapietro F Elice 2004 KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication Haematologica 89 920 925
8. DH Christiansen MK Andersen F Desta J Pedersen-Bjergaard 2005 Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia Leukemia 19 2232 2240 10.1038/sj.leu.2404009 (Pubitemid 41741619)
9. H Niimi H Harada Y Harada Y Ding J Imagawa T Inaba 2006 Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations Leukemia 20 635 644 10.1038/sj.leu.2404136
10. N Matsuno M Osato N Yamashita M Yanagida T Nanri T Fukushima 2003 Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype Leukemia 17 2492 2499 10.1038/sj.leu.2403160 (Pubitemid 38072589)
11. C Roumier V Eclache M Imbert F Davi E MacIntyre R Garand 2003 M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH) Blood 101 1277 1283 10.1182/blood-2002-05-1474 (Pubitemid 36182496)
12. C Callens S Chevret JM Cayuela B Cassinat E Raffoux S de Botton 2005 Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group Leukemia 19 1153 1160 10.1038/sj.leu.2403790 (Pubitemid 40945998)
13. RE Gale R Hills AR Pizzey PD Kottaridis D Swirsky AF Gilkes 2005 Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia Blood 106 3768 3776 10.1182/blood-2005-04-1746 (Pubitemid 41739011)
14. P Arrigoni C Beretta D Silvestri V Rossi C Rizzari MG Valsecchi 2003 FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia Br J Haematol 120 89 92 10.1046/j.1365-2141.2003.04032.x (Pubitemid 36056913)
15. NI Noguera M Breccia M Divona D Diverio V Costa S De Santis 2002 Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol Leukemia 16 2185 2189 10.1038/sj.leu.2402723 (Pubitemid 35331832)
16. B Kainz D Heintel R Marculescu I Schwarzinger W Sperr T Le 2002 Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16) Hematol J 3 283 289 10.1038/sj.thj.6200196 (Pubitemid 36167783)
17. T Taketani T Taki K Sugita Y Furuichi E Ishii R Hanada 2004 FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy Blood 103 1085 1088 10.1182/blood-2003-02-0418 (Pubitemid 38129575)
18. DC Liang LY Shih JF Fu HY Li HI Wang IJ Hung 2006 K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements Cancer 106 950 956 10.1002/cncr.21687 (Pubitemid 43238464)
19. RE Gale C Green C Allen AJ Mead AK Burnett RK Hills 2008 The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia Blood 111 2776 2784 10.1182/blood-2007-08-109090
20. H Kiyoi T Naoe Y Nakano S Yokota S Minami S Miyawaki 1999 Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia Blood 93 3074 3080
21. DL Stirewalt KJ Kopecky S Meshinchi FR Appelbaum ML Slovak CL Willman 2001 FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia Blood 97 3589 3595 10.1182/blood.V97.11.3589
22. LM Kelly JL Kutok IR Williams CL Boulton SM Amaral DP Curley 2002 PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model Proc Natl Acad Sci USA 99 8283 8288 10.1073/pnas.122233699 (Pubitemid 34651044)
23. JK Warner JC Wang K Takenaka S Doulatov JL McKenzie L Harrington 2005 Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells Leukemia 19 1794 1805 10.1038/sj.leu.2403917 (Pubitemid 41486158)
24. DG Gilliland JD Griffin 2002 Role of FLT3 in leukemia Curr Opin Hematol 9 274 281 10.1097/00062752-200207000-00003 (Pubitemid 34596870)
25. C Schessl VP Rawat M Cusan A Deshpande TM Kohl PM Rosten 2005 The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice J Clin Invest 115 2159 2168 10.1172/JCI24225 (Pubitemid 41134157)
26. GM Cuenco R Ren 2001 Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia Oncogene 20 8236 8248 10.1038/sj.onc.1205095 (Pubitemid 34038211)
27. R Ono H Nakajima K Ozaki H Kumagai T Kawashima T Taki 2005 Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis J Clin Invest 115 919 929
28. IT Chan JL Kutok IR Williams S Cohen S Moore H Shigematsu 2006 Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease Blood 108 1708 1715 10.1182/blood-2006-04-015040 (Pubitemid 44316141)
29. GW Reuther QT Lambert JF Rebhun MA Caligiuri LA Quilliam CJ Der 2002 RasGRP4 is a novel Ras activator isolated from acute myeloid leukemia J Biol Chem 277 30508 30514 10.1074/jbc.M111330200 (Pubitemid 34970743)
30. Y Yang L Li GW Wong SA Krilis MS Madhusudhan A Sali 2002 RasGRP4, a new mast cell-restricted Ras guanine nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs Identification of defective variants of this signaling protein in asthma, mastocytosis, and mast cell leukemia patients and demonstration of the importance of RasGRP4 in mast cell development and function J Biol Chem 277 25756 25774 10.1074/jbc.M202575200 (Pubitemid 34951897)
31. T Kitamura M Onishi S Kinoshita A Shibuya A Miyajima GP Nolan 1995 Efficient screening of retroviral cDNA expression libraries Proc Natl Acad Sci USA 92 9146 9150 10.1073/pnas.92.20.9146
32. T Kitamura Y Koshino F Shibata T Oki H Nakajima T Nosaka 2003 Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics Exp Hematol 31 1007 1014
33. H Harada Y Harada H Niimi T Kyo A Kimura T Inaba 2004 High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia Blood 103 2316 2324 10.1182/blood-2003-09-3074 (Pubitemid 38326252)
34. K Izawa J Kitaura Y Yamanishi T Matsuoka T Oki F Shibata 2007 Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3 J Biol Chem 282 17997 18008 10.1074/jbc.M701100200 (Pubitemid 47100247)
35. N Watanabe-Okochi J Kitaura R Ono H Harada Y Harada Y Komeno 2008 AML1 mutations induced MDS and MDS/AML in a mouse BMT model Blood 111 4297 4308 10.1182/blood-2007-01-068346
36. MA Reuss-Borst HJ Bühring H Schmidt CA Müller 1994 AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression Leukemia 8 258 263
37. Y Chinen T Taki K Nishida D Shimizu T Okuda N Yoshida 2008 Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA Oncogene 27 2249 2256 10.1038/sj.onc.1210857
38. FM Mikhail L Coignet N Hatem ZI Mourad HM Farawela DM El Kaffash 2004 A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T cell acute lymphoblastic leukemia Genes Chromosomes Cancer 39 110 118 10.1002/gcc.10302 (Pubitemid 38056083)
39. T Kitamura 1998 New experimental approaches in retrovirus-mediated expression screening Int J Hematol 67 351 359 10.1016/S0925-5710(98)00025-5